SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Pierpaolo Trimboli, Giorgio Treglia, Emma Condorelli, Francesco Romanelli, Anna Crescenzi, Massimo Bongiovanni, Luca Giovanella, BRAF-mutated carcinomas among thyroid nodules with prior indeterminate FNA report: a systematic review and meta-analysis, Clinical Endocrinology, 2015, 83, 1
  2. 2
    Naif Fnais, Charlene Soobiah, Khalid AL-Qahtani, Jemila S. Hamid, Laure Perrier, Sharon E. Straus, Andrea C. Tricco, Diagnostic Value of Fine Needle Aspiration BRAFV600E Mutation Analysis in Papillary Thyroid Cancer: A systematic review and meta-analysis, Human Pathology, 2015,

    CrossRef

  3. 3
    E. Vigliar, V. Varone, G. Pettinato, C. Bellevicine, G. Troncone, How should a follicular adenoma with papillary architecture be classified on thyroid FNA? Case report with histological correlation, Cytopathology, 2015, 26, 3
  4. 4
    Linwah Yip, Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy, Journal of Surgical Oncology, 2015, 111, 1
  5. 5
    Seo Ki Kim, Jun Ho Lee, Jung-Woo Woo, Inhye Park, Jun-Ho Choe, Jung-Han Kim, Jee Soo Kim, Prediction Table and Nomogram as Tools for Diagnosis of Papillary Thyroid Carcinoma, Medicine, 2015, 94, 21, e760

    CrossRef

  6. 6
    L. Capelli, C. Marfisi, M. Puccetti, L. Saragoni, F. De Paola, A. Zaccaroni, E. Chiadini, L. Gagliardi, G. Ferretti, W. Zoli, P. Ulivi, Role of BRAF molecular analysis in the management of papillary thyroid carcinoma: analysis of cytological and histological samples, Cytopathology, 2015, 26, 3
  7. 7
    N. Paul Ohori, Karen E. Schoedel, Ancillary Studies in Thyroid Cytopathology, Surgical Pathology Clinics, 2014, 7, 1, 47

    CrossRef

  8. 8
    Anna Guerra, Vincenza Di Stasi, Pio Zeppa, Antongiulio Faggiano, Vincenzo Marotta, Mario Vitale, BRAF V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto’s thyroiditis is a reliable assay, Endocrine, 2014, 45, 2, 249

    CrossRef

  9. 9
    Linwah Yip, Robert L. Ferris, Clinical Application of Molecular Testing of Fine-needle Aspiration Specimens in Thyroid Nodules, Otolaryngologic Clinics of North America, 2014, 47, 4, 557

    CrossRef

  10. 10
    Marius I. Ilie, Sandra Lassalle, Elodie Long-Mira, Christelle Bonnetaud, Olivier Bordone, Virginie Lespinet, Aude Lamy, Jean-Christophe Sabourin, Juliette Haudebourg, Catherine Butori, Nicolas Guevara, Isabelle Peyrottes, Jean-Louis Sadoul, Alexandre Bozec, José Santini, David Capper, Andreas von Deimling, Jean-François Emile, Véronique Hofman, Paul Hofman, Diagnostic Value of Immunohistochemistry for the Detection of theBRAFV600EMutation in Papillary Thyroid Carcinoma: Comparative Analysis with Three DNA-Based Assays, Thyroid, 2014, 24, 5, 858

    CrossRef

  11. 11
    Linwah Yip, Molecular diagnostic testing and the indeterminate thyroid nodule, Current Opinion in Oncology, 2014, 26, 1, 8

    CrossRef

  12. 12
    Michiya Nishino, Helen H. Wang, Should the thyroid AUS/FLUS category be further stratified by malignancy risk?, Cancer Cytopathology, 2014, 122, 7
  13. 13
    Jiyeon Hyeon, Soomin Ahn, Jung Hee Shin, Young Lyun Oh, The prediction of malignant risk in the category “atypia of undetermined significance/follicular lesion of undetermined significance” of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results, Cancer Cytopathology, 2014, 122, 5
  14. 14
    Won Sang Yoo, Hoon Sung Choi, Sun Wook Cho, Jae Hoon Moon, Kyung Won Kim, Hyo Jin Park, So Yeon Park, Sang Il Choi, Sung Hee Choi, Soo Lim, Ka Hee Yi, Do Joon Park, Hak Chul Jang, Young Joo Park, The role of ultrasound findings in the management of thyroid nodules with atypia or follicular lesions of undetermined significance, Clinical Endocrinology, 2014, 80, 5
  15. 15
    Lisa A. Radkay, Simion I. Chiosea, Raja R. Seethala, Steven P. Hodak, Shane O. LeBeau, Linwah Yip, Kelly L. McCoy, Sally E. Carty, Karen E. Schoedel, Marina N. Nikiforova, Yuri E. Nikiforov, N. Paul Ohori, Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics, Cancer Cytopathology, 2014, 122, 12
  16. 16
    Linwah Yip, Use of Molecular Markers for Cytologically Indeterminate Thyroid Nodules to Optimize Surgical Management, Current Surgery Reports, 2014, 2, 1

    CrossRef

  17. 17
    N. Paul Ohori, Jenna Wolfe, Steven P. Hodak, Shane O. LeBeau, Linwah Yip, Sally E. Carty, Umamaheswar Duvvuri, Karen E. Schoedel, Marina N. Nikiforova, Yuri E. Nikiforov, “Colloid-Rich” follicular neoplasm/suspicious for follicular neoplasm thyroid fine-needle aspiration specimens: Cytologic, histologic, and molecular basis for considering an alternate view, Cancer Cytopathology, 2013, 121, 12